1. 1. Friedman DS, O'Colmain BJ, Munoz B, et al, for the Eye Diseases Prevalence Research Group. Prevalence of agerelated macular degeneration in the United States. Arch Ophthalmol. 2004;122:564-572.
2. 2. Bressler NM, Bressler SB, Congdon NG, et al, for the Age- Related Eye Disease Study Research Group. Potential public health impact of Age-Related Eye Disease Study Results: AREDS report no. 11. Arch Ophthalmol. 2003;121:1621- 1624.
3. 3. Hyman L. Epidemiology of AMD. In: Hampton GR, Nelsen PT, eds. Age-Related Macular Degeneration: Principles and Practice. New York: Raven Press; 1992: 1-35.
4. 4. Ferris FL III, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984;102:1640-1642.
5. 5. Chew EY, Clemons TE, Agron E, et al; Age-Related Eye Disease Study Research Group. Long-Term Effects of Vitamins C and E, β-Carotene, and Zinc on Age-Related Macular Degeneration: AREDS Report No. 35. Ophthalmology. 2013 Apr 10, in press.